Butterfly Network, Inc.
BFLYHealthcareNASDAQMedical Devices
Scan Results
Daily timeframePart of the healthcare sector, Butterfly Network, Inc. (BFLY) is listed under Medical Devices. The $1.95B market capitalization puts BFLY squarely in small-cap range for its industry. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market.
Market Cap
$1.95B
Beta
2.04
P/E (TTM)
—
P/E (Fwd)
-108.30
EPS (TTM)
$-0.29
EPS (Fwd)
$-0.07
ROE
-35.5%
ROA
-10.5%
Cash
$124.7M
Total Debt
$19.1M
Free CF
$925,625
52W Change
224.9%
Annual Financials
Cash vs Debt
Where BFLY stands vs its 150-day and 200-day moving averages
As of the October 12, 2026 close, BFLY finished 27.91% above its 150-day moving average ($6.45) and 42.24% above its 200-day moving average ($5.80). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is BFLY overbought or oversold?
At the October 12, 2026 close, BFLY's RSI(14) was 50.9, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $124.7M in cash comfortably exceeding the $19.1M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Free cash flow comes in at $926K, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at -35.5%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $62.6M (2021) to $97.6M (2025), reflecting a 56% increase over the period.
Butterfly Network, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. With cash comfortably exceeding debt, BFLY has financial flexibility that may help navigate uncertain periods. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Butterfly Network, Inc.'s trajectory.